Review



pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1  (BioNTech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    BioNTech pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1
    Pfizer Biontech Covid 19 Bivalent Mrna Vaccine (Original Omicron Ba.1, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/10__7883_slash_yoken__jjid__2024__116-1-19-19
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Control:

    Article Title: Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
    Article Snippet: https://doi.org/10.1016/j.vaccine.2023.07.010 0264-410X/ 2023 Elsevier Ltd. All rights reserved.. ⇑ Corresponding author.. E-mail address: katherine_yih@harvardpilgrim.org (W. Katherine Yih).

    Article Title: Ischemic Stroke after Bivalent COVID-19 Vaccination: A Self-Controlled Case Series Study
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged ≥12 years) or the Moderna bivalent COVID-19 vaccine (for individuals aged ≥18 years) between September 1, 2022 and March 31, 2023.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: On August 31, 2022, the US Food and Drug Administration (FDA) granted emergency use authorizations for the Pfizer-BioNTech bivalent COVID-19 vaccine for individuals aged 12 years and older and the Moderna bivalent COVID-19 vaccine for individuals aged 18 years and older [1,2].

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: For the Pfizer-BioNTech bivalent COVID-19 vaccine, there were 103 electronically identified ischemic stroke events in the 21-day postvaccination risk interval, 954 events in the control interval, and 3049 events among NBR; the overall RI was 0.90 (95% CI 0.73-1.12; Multimedia Appendix 3).

    Article Title: Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
    Article Snippet: The Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines are FDA-approved to be administered as a solitary booster dose.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged 12 years and older ) or the Moderna bivalent COVID-19 vaccine (for individuals aged 18 years and older) between September 1, 2022, and March 31, 2023.

    Article Title: Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system.
    Article Snippet: In the Vaccine Safety Datalink COVID-19 vaccine rapid cycle analysis, a possible safety signal for ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine was observed in individuals 65 years and older, particularly among those who had received concomitant high-dose or adjuvanted influenza vaccination [12,13].

    Article Title: Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022.
    Article Snippet: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose.

    Derivative Assay:

    Article Title: Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
    Article Snippet: https://doi.org/10.1016/j.vaccine.2023.07.010 0264-410X/ 2023 Elsevier Ltd. All rights reserved.. ⇑ Corresponding author.. E-mail address: katherine_yih@harvardpilgrim.org (W. Katherine Yih).

    Article Title: Ischemic Stroke after Bivalent COVID-19 Vaccination: A Self-Controlled Case Series Study
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged ≥12 years) or the Moderna bivalent COVID-19 vaccine (for individuals aged ≥18 years) between September 1, 2022 and March 31, 2023.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: On August 31, 2022, the US Food and Drug Administration (FDA) granted emergency use authorizations for the Pfizer-BioNTech bivalent COVID-19 vaccine for individuals aged 12 years and older and the Moderna bivalent COVID-19 vaccine for individuals aged 18 years and older [1,2].

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: For the Pfizer-BioNTech bivalent COVID-19 vaccine, there were 103 electronically identified ischemic stroke events in the 21-day postvaccination risk interval, 954 events in the control interval, and 3049 events among NBR; the overall RI was 0.90 (95% CI 0.73-1.12; Multimedia Appendix 3).

    Article Title: Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
    Article Snippet: The Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines are FDA-approved to be administered as a solitary booster dose.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged 12 years and older ) or the Moderna bivalent COVID-19 vaccine (for individuals aged 18 years and older) between September 1, 2022, and March 31, 2023.

    Article Title: Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system.
    Article Snippet: In the Vaccine Safety Datalink COVID-19 vaccine rapid cycle analysis, a possible safety signal for ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine was observed in individuals 65 years and older, particularly among those who had received concomitant high-dose or adjuvanted influenza vaccination [12,13].

    Article Title: Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022.
    Article Snippet: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose.

    Variant Assay:

    Article Title: Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink.
    Article Snippet: https://doi.org/10.1016/j.vaccine.2023.07.010 0264-410X/ 2023 Elsevier Ltd. All rights reserved.. ⇑ Corresponding author.. E-mail address: katherine_yih@harvardpilgrim.org (W. Katherine Yih).

    Article Title: Ischemic Stroke after Bivalent COVID-19 Vaccination: A Self-Controlled Case Series Study
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged ≥12 years) or the Moderna bivalent COVID-19 vaccine (for individuals aged ≥18 years) between September 1, 2022 and March 31, 2023.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: On August 31, 2022, the US Food and Drug Administration (FDA) granted emergency use authorizations for the Pfizer-BioNTech bivalent COVID-19 vaccine for individuals aged 12 years and older and the Moderna bivalent COVID-19 vaccine for individuals aged 18 years and older [1,2].

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: For the Pfizer-BioNTech bivalent COVID-19 vaccine, there were 103 electronically identified ischemic stroke events in the 21-day postvaccination risk interval, 954 events in the control interval, and 3049 events among NBR; the overall RI was 0.90 (95% CI 0.73-1.12; Multimedia Appendix 3).

    Article Title: Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
    Article Snippet: The Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines are FDA-approved to be administered as a solitary booster dose.

    Article Title: Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.
    Article Snippet: The exposure was defined as the administration of the Pfizer-BioNTech bivalent COVID-19 vaccine (for individuals aged 12 years and older ) or the Moderna bivalent COVID-19 vaccine (for individuals aged 18 years and older) between September 1, 2022, and March 31, 2023.

    Article Title: Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system.
    Article Snippet: In the Vaccine Safety Datalink COVID-19 vaccine rapid cycle analysis, a possible safety signal for ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine was observed in individuals 65 years and older, particularly among those who had received concomitant high-dose or adjuvanted influenza vaccination [12,13].

    Article Title: Attitudes toward COVID-19 and Other Vaccines: Comparing Parents to Other Adults, September 2022.
    Article Snippet: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose.



    Similar Products

    90
    BioNTech pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1
    Pfizer Biontech Covid 19 Bivalent Mrna Vaccine (Original Omicron Ba.1, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/10__7883_slash_yoken__jjid__2024__116-1-19-19
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 bivalent mrna vaccine (original omicron ba.1 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    BioNTech pfizer-biontech covid-19 vaccine, bivalent
    Pfizer Biontech Covid 19 Vaccine, Bivalent, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/pm39535316-142-14-14
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 vaccine, bivalent - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    BioNTech pfizer-biontech covid-19 vaccine (bivalent, original omicron ba.4/ba.5
    Pfizer Biontech Covid 19 Vaccine (Bivalent, Original Omicron Ba.4/Ba.5, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/bnt162b2/pmc11609509-96-9-9
    Average 90 stars, based on 1 article reviews
    pfizer-biontech covid-19 vaccine (bivalent, original omicron ba.4/ba.5 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    BioNTech pfizer-biontech bivalent covid-19 vaccine
    Pfizer Biontech Bivalent Covid 19 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/pm38916940-110-2-2
    Average 90 stars, based on 1 article reviews
    pfizer-biontech bivalent covid-19 vaccine - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    BioNTech pfizer-biontech bivalent covid-19 vaccination
    Pfizer Biontech Bivalent Covid 19 Vaccination, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/pm38916940-130-15-15
    Average 90 stars, based on 1 article reviews
    pfizer-biontech bivalent covid-19 vaccination - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Moderna bivalent mrna vaccine or pfizer-biontech bivalent covid-19 vaccine dose
    Bivalent Mrna Vaccine Or Pfizer Biontech Bivalent Covid 19 Vaccine Dose, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/bivalent+mrna+vaccine+or+pfizer+biontech+bivalent+covid+19+vaccine+dose/pm38897685-78-21-24
    Average 90 stars, based on 1 article reviews
    bivalent mrna vaccine or pfizer-biontech bivalent covid-19 vaccine dose - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    BioNTech bivalent pfizer-biontech covid-19 vaccine
    Reported and scenario-based uptake of <t>COVID-19</t> vaccines over time in adults above the age of 20y (top) and 0-19-year-old children (bottom). The uptake is presented in terms of the absolute number of doses (left axis) and as a percentage of the target group (right axis)
    Bivalent Pfizer Biontech Covid 19 Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pfizer-biontech+bivalent+covid-19+vaccine/pfizer+biontech+bivalent+vaccine/pmc11047051-296-19-20
    Average 90 stars, based on 1 article reviews
    bivalent pfizer-biontech covid-19 vaccine - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Reported and scenario-based uptake of COVID-19 vaccines over time in adults above the age of 20y (top) and 0-19-year-old children (bottom). The uptake is presented in terms of the absolute number of doses (left axis) and as a percentage of the target group (right axis)

    Journal: BMC Public Health

    Article Title: The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)

    doi: 10.1186/s12889-024-18576-w

    Figure Lengend Snippet: Reported and scenario-based uptake of COVID-19 vaccines over time in adults above the age of 20y (top) and 0-19-year-old children (bottom). The uptake is presented in terms of the absolute number of doses (left axis) and as a percentage of the target group (right axis)

    Article Snippet: Previous work, based on a combined-cohort Markov decision tree model for the US, showed that booster doses of the bivalent Pfizer-BioNTech COVID-19 vaccine generates notable public health gains [ ].

    Techniques: Vaccines

    Projected daily hospital admissions with COVID-19 in Belgium with adjusted vaccine uptake for 5-11-year old children or adults. The curves represent the time-dependent point-wise average of 400 stochastic realisations, while the 95% credible interval is shown by the shaded area. Related figures on hospital occupancy, ICU load and mortality are included in the

    Journal: BMC Public Health

    Article Title: The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)

    doi: 10.1186/s12889-024-18576-w

    Figure Lengend Snippet: Projected daily hospital admissions with COVID-19 in Belgium with adjusted vaccine uptake for 5-11-year old children or adults. The curves represent the time-dependent point-wise average of 400 stochastic realisations, while the 95% credible interval is shown by the shaded area. Related figures on hospital occupancy, ICU load and mortality are included in the

    Article Snippet: Previous work, based on a combined-cohort Markov decision tree model for the US, showed that booster doses of the bivalent Pfizer-BioNTech COVID-19 vaccine generates notable public health gains [ ].

    Techniques: